256 related articles for article (PubMed ID: 32356584)
21. Synthesis, cytotoxicity and molecular modelling studies of new phenylcinnamide derivatives as potent inhibitors of cholinesterases.
Saeed A; Mahesar PA; Zaib S; Khan MS; Matin A; Shahid M; Iqbal J
Eur J Med Chem; 2014 May; 78():43-53. PubMed ID: 24675179
[TBL] [Abstract][Full Text] [Related]
22. Design, facile synthesis, and evaluation of novel spiro- and pyrazolo[1,5-c]quinazolines as cholinesterase inhibitors: Molecular docking and MM/GBSA studies.
Gálvez J; Polo S; Insuasty B; Gutiérrez M; Cáceres D; Alzate-Morales JH; De-la-Torre P; Quiroga J
Comput Biol Chem; 2018 Jun; 74():218-229. PubMed ID: 29655025
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and anti-cholinesterase activity of new 7-hydroxycoumarin derivatives.
Alipour M; Khoobi M; Moradi A; Nadri H; Homayouni Moghadam F; Emami S; Hasanpour Z; Foroumadi A; Shafiee A
Eur J Med Chem; 2014 Jul; 82():536-44. PubMed ID: 24941128
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, in vitro and in vivo evaluation of novel substituted N-(4-(2-(4-benzylpiperazin-1-yl)ethoxy)phenyl)-N-methyl-quinazolin-4-amines as potent antitumor agents.
Cao D; Wang X; Lei L; Ma L; Wang F; Wang C; Tang M; Xiang W; Wang T; Li H; Chen L
Bioorg Med Chem Lett; 2016 Apr; 26(8):1931-5. PubMed ID: 26979159
[TBL] [Abstract][Full Text] [Related]
25. Biological Evaluation, Molecular Docking, and SAR Studies of Novel 2-(2,4-Dihydroxyphenyl)-1
Matysiak J; Skrzypek A; Karpińska M; Czarnecka K; Szymański P; Bajda M; Niewiadomy A
Biomolecules; 2019 Dec; 9(12):. PubMed ID: 31842463
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis, and anti-proliferative evaluation of new quinazolin-4(3H)-ones as potential VEGFR-2 inhibitors.
El-Adl K; El-Helby AA; Ayyad RR; Mahdy HA; Khalifa MM; Elnagar HA; Mehany ABM; Metwaly AM; Elhendawy MA; Radwan MM; ElSohly MA; Eissa IH
Bioorg Med Chem; 2021 Jan; 29():115872. PubMed ID: 33214036
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and Biological Evaluation of New 1,3,4-Oxadiazoles as Potential Anticancer Agents and Enzyme Inhibitors.
Yurttaş L; Çavuşoğlu BK; Çiftçi GA; Temel HE
Anticancer Agents Med Chem; 2018; 18(6):914-921. PubMed ID: 29577865
[TBL] [Abstract][Full Text] [Related]
28. 2-((1-Phenyl-1H-1,2,3-triazol-4-yl)methyl)-2-azabicyclo[3.2.1]octan-3-one derivatives: Simplification and modification of aconitine scaffold for the discovery of novel anticancer agents.
Zhang Y; Zhang TJ; Li XY; Liang JW; Tu S; Xu HL; Xue WH; Qian XH; Zhang ZH; Zhang X; Meng FH
Eur J Med Chem; 2021 Jan; 210():112988. PubMed ID: 33189438
[TBL] [Abstract][Full Text] [Related]
29. Design, combinatorial synthesis and biological evaluations of novel 3-amino-1'-((1-aryl-1H-1,2,3-triazol-5-yl)methyl)-2'-oxospiro[benzo[a] pyrano[2,3-c]phenazine-1,3'-indoline]-2-carbonitrile antitumor hybrid molecules.
Lu Y; Wang L; Wang X; Xi T; Liao J; Wang Z; Jiang F
Eur J Med Chem; 2017 Jul; 135():125-141. PubMed ID: 28441581
[TBL] [Abstract][Full Text] [Related]
30. Benzofuran-derived benzylpyridinium bromides as potent acetylcholinesterase inhibitors.
Baharloo F; Moslemin MH; Nadri H; Asadipour A; Mahdavi M; Emami S; Firoozpour L; Mohebat R; Shafiee A; Foroumadi A
Eur J Med Chem; 2015 Mar; 93():196-201. PubMed ID: 25681712
[TBL] [Abstract][Full Text] [Related]
31. 4β-[(4-Alkyl)-1,2,3-triazol-1-yl] podophyllotoxins as anticancer compounds: design, synthesis and biological evaluation.
Reddy DM; Srinivas J; Chashoo G; Saxena AK; Sampath Kumar HM
Eur J Med Chem; 2011 Jun; 46(6):1983-91. PubMed ID: 21477899
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and biological evaluation of 2,3-dihydro-5,6-dimethoxy-1H-inden-1-one and piperazinium salt hybrid derivatives as hAChE and hBuChE enzyme inhibitors.
Mozaffarnia S; Teimuri-Mofrad R; Rashidi MR
Eur J Med Chem; 2020 Apr; 191():112140. PubMed ID: 32088494
[TBL] [Abstract][Full Text] [Related]
33. Novel Hydroxamic Acids Incorporating 1-((1H-1,2,3-Triazol-4-yl)methyl)- 3-substituted-2-oxoindolines: Synthesis, Biological Evaluation and SAR Analysis.
Dung DTM; Huan NV; Cam DM; Hieu DC; Hai PT; Huong LT; Kim J; Choi JE; Kang JS; Han SB; Nam NH
Med Chem; 2018; 14(8):831-850. PubMed ID: 29807520
[TBL] [Abstract][Full Text] [Related]
34. Indomethacin based new triazolothiadiazine derivatives: Synthesis, evaluation of their anticancer effects on T98 human glioma cell line related to COX-2 inhibition and docking studies.
Sever B; Altıntop MD; Kuş G; Özkurt M; Özdemir A; Kaplancıklı ZA
Eur J Med Chem; 2016 May; 113():179-86. PubMed ID: 26927686
[TBL] [Abstract][Full Text] [Related]
35. Tyrosol 1,2,3-triazole analogues as new acetylcholinesterase (AChE) inhibitors.
Bousada GM; de Sousa BL; Furlani G; Agrizzi AP; Ferreira PG; Leite JPV; Mendes TAO; Varejão EVV; Pilau EJ; Dos Santos MH
Comput Biol Chem; 2020 Oct; 88():107359. PubMed ID: 32853899
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and cytotoxic activity on human cancer cells of carbamate derivatives of 4β-(1,2,3-triazol-1-yl)podophyllotoxin.
Liu JF; Sang CY; Xu XH; Zhang LL; Yang X; Hui L; Zhang JB; Chen SW
Eur J Med Chem; 2013 Jun; 64():621-8. PubMed ID: 23711769
[TBL] [Abstract][Full Text] [Related]
37. Design, Synthesis, Biological Evaluation, and Docking Study of Acetylcholinesterase Inhibitors: New Acridone-1,2,4-oxadiazole-1,2,3-triazole Hybrids.
Mohammadi-Khanaposhtani M; Mahdavi M; Saeedi M; Sabourian R; Safavi M; Khanavi M; Foroumadi A; Shafiee A; Akbarzadeh T
Chem Biol Drug Des; 2015 Dec; 86(6):1425-32. PubMed ID: 26077890
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological evaluation of pyrazolo-triazole hybrids as cytotoxic and apoptosis inducing agents.
Srinivasa Reddy T; Kulhari H; Ganga Reddy V; Subba Rao AV; Bansal V; Kamal A; Shukla R
Org Biomol Chem; 2015 Oct; 13(40):10136-49. PubMed ID: 26346902
[TBL] [Abstract][Full Text] [Related]
39. New benzyl pyridinium derivatives bearing 2,4-dioxochroman moiety as potent agents for treatment of Alzheimer's disease: Design, synthesis, biological evaluation, and docking study.
Mollazadeh M; Mohammadi-Khanaposhtani M; Zonouzi A; Nadri H; Najafi Z; Larijani B; Mahdavi M
Bioorg Chem; 2019 Jun; 87():506-515. PubMed ID: 30928873
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis, and structure-activity relationships of a series of 3-[2-(1-benzylpiperidin-4-yl)ethylamino]pyridazine derivatives as acetylcholinesterase inhibitors.
Contreras JM; Parrot I; Sippl W; Rival YM; Wermuth CG
J Med Chem; 2001 Aug; 44(17):2707-18. PubMed ID: 11495583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]